Skip to search formSkip to main contentSkip to account menu

Bezalip

Known as: Eulitop 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Bezafibrate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
[Acute severe myositis due to bezafibrate treatment].
The second generation fibric acid derivative, bezafibrate (Bezalip, Norlip) is widely used as a hypolipemic agent throughout… 
1988
1988
Trial of bezafibrate (Bezalip) in diabetic patients with primary hypertriglyceridaemia
A trial of a new hyperlipidemic drug, Bezafibrate, was taken up in diabetic patients with primary hyperlipidemia. The study was… 
1987
1987
[Indications for and the therapeutic action of hypolipidemic agents in patients with hyperlipoproteinemias].
Seventy three patients with hyperlipoproteinemia (HLP) type II and IV were divided into three groups and treated with different… 
1984
1984
A therapeutic trial of bezafibrate on patients with hyperlipidemia with or without diabetes mellitus.
Bezalip (bezafibrate), at an oral dosage of 200 mg three times a day, has been used on 12 patients with idiopathic hyperlipidemia… 
1983
1983
Bezafibrate.
1983
1983
[Effect of 1 month's treatment with Bezalip on the serum lipids and lipoproteins of patients with different types of hyperlipoproteinemias].
The effect of one-month bezalip (600 mg daily) outpatient department treatment was studied on serum lipids and lipoproteins of 34… 
1983
1983
Effect of clofibrate and adaptation to low temperatures on liver enzyme systems for lipid catabolism in rats
Besides mitochondria the peroxisomes of mammals play an active role in lipid catabolism. Enzyme systems of 0-oxidation of long… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)